HK Stock Market Move | JXR (01951) rises by over 7%, assisted reproductive projects in multiple regions included in medical insurance, institutions bullish on company's market share increase.

JXR (01951) rose by more than 7%, up 7.49% as of the time of writing, with a closing price of HKD 2.44 and a trading volume of HKD 36.15 million. On the news front, several regions have recently announced the inclusion of multiple assisted reproductive medical projects in medical insurance. Hubei province has included 8 assisted reproductive medical service projects, such as "egg retrieval", in the scope of medical insurance payments, effective from September 15; Guangdong province has included 8 assisted reproductive medical service projects, such as "egg retrieval", in the scope of medical insurance payments, effective from October 1; Yunnan province has included 12 assisted reproductive medical service projects, such as "egg retrieval", in the scope of medical insurance payments, effective from October 10. It is reported that Beijing and Guangxi will include assisted reproduction in the scope of medical insurance reimbursement by 2023, followed by several provinces. By September 2024, a total of 20 provinces have implemented this policy. In addition, Guangdong and Yunnan have also clarified that they will include assisted reproduction in October, with at least 22 provinces expected to do so. HAITONG INT'L believes that the progressive promotion of assisted reproduction into medical insurance policies is expected to catalyze the company's performance. Huachuang Securities stated that with the expectation of accelerated industry penetration in the future due to assisted reproduction being included in medical insurance, the company's market share (number of egg retrieval cycles) is expected to steadily increase.